Valuation: COMPASS Pathways plc

Market Cap 1.97B 1.68B 1.58B 1.44B 2.72B 188B 2.74B 18.58B 7.24B 94.55B 7.38B 7.22B 313B P/E 2026 *
-6.92x
P/E 2027 * -8.88x
Enterprise Value 1.61B 1.38B 1.29B 1.18B 2.22B 153B 2.24B 15.19B 5.92B 77.29B 6.03B 5.9B 256B EV / Sales 2026 *
-
EV / Sales 2027 * 38.6x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+4.79%
1 week+8.45%
Current month+31.10%
1 month+32.15%
3 months+25.99%
6 months+86.23%
Current year+115.65%
1 week 13.08
Extreme 13.08
14.92
1 month 10.59
Extreme 10.59
14.92
Current year 4.88
Extreme 4.88
15.4
1 year 4.4
Extreme 4.4
15.4
3 years 2.25
Extreme 2.25
15.4
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 31/07/2022
Director of Finance/CFO 54 29/02/2024
Chief Tech/Sci/R&D Officer 66 30/04/2024
Director TitleAgeSince
Chairman 74 28/03/2024
Director/Board Member 69 31/03/2020
Director/Board Member 67 28/02/2021
Date Insider Type Main position Quantity % Market Cap.
03/08/26 Tax

Chief Executive Officer

-5,962 0.0062%
26/03/26 Free

Chief Executive Officer

542,815 0.5658%
11/03/26 Tax

Chief Financial Officer

1,781 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
+4.79%+8.45%+222.78%+68.14% 1.97B
+1.02%+4.84%+4.80%+24.36% 51.21B
-0.09%-0.29%+471.14%+564.30% 45.35B
-0.32%+7.54%+35.72%+20.37% 42.84B
+1.18%+3.82%+19.99%+89.24% 42.29B
-2.27%-5.67%+14.55%+50.34% 32.15B
-0.96%+2.84%+32.44%+142.88% 17.31B
+0.41%+2.26% - - 16.55B
+1.12%+5.83%+8.37%+32.33% 14.84B
-0.31%+3.84%+83.91%+49.85% 14.25B
Average +0.44%+3.10%+99.30%+115.76% 27.88B
Weighted average by Cap. +0.06%+2.90%+102.11%+140.73%

Financials

2026 *2027 *
Net sales - 39.7M 34M 31.82M 29.09M 54.91M 3.79B 55.41M 375M 146M 1.91B 149M 146M 6.32B
Net income -299M -256M -239M -219M -413M -28.49B -417M -2.82B -1.1B -14.36B -1.12B -1.1B -47.54B -252M -216M -202M -185M -348M -24.03B -352M -2.38B -928M -12.11B -946M -925M -40.1B
Net Debt -359M -307M -288M -263M -497M -34.25B -501M -3.39B -1.32B -17.26B -1.35B -1.32B -57.16B -432M -370M -346M -317M -598M -41.23B -603M -4.08B -1.59B -20.78B -1.62B -1.59B -68.81B
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
25/08/26 US$14.88 +4.79% 2,270,335
24/08/26 US$14.20 +6.53% 2,776,364
21/08/26 US$13.33 -3.55% 2,084,620
20/08/26 US$13.82 -1.36% 2,038,389
19/08/26 US$14.01 +0.79% 2,836,065
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
14.88USD
Average target price
23.75USD
Spread / Average Target
+59.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock